Repurposing of Drugs for Antibacterial Activities on Selected ESKAPE Bacteria <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Bacteria</td><td class="align_center">MIC of ciprofloxacin only (<i>μ</i>g/ml)</td><td class="align_center">MIC of ciprofloxacin combined with curcumin (<i>μ</i>g/ml)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left"><i>P. aeruginosa</i></td><td class="align_center">0.5</td><td class="align_center">0.0625</td></tr><tr><td class="align_left"><i>S. aureus</i></td><td class="align_center">0.25</td><td class="align_center">0.0625</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The effects of combining ciprofloxacin and curcumin on the MIC of ciprofloxacin against <i>P. aeruginosa</i> and <i>S. aureus</i>.</div>

International Journal of Microbiology

tab2

Table 2

Table 2: Repurposing of Drugs for Antibacterial Activities on Selected ESKAPE Bacteria <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> 

International Journal of Microbiology

Repurposing of Drugs for Antibacterial Activities on Selected ESKAPE Bacteria Staphylococcus aureus and Pseudomonas aeruginosa

Table 2